The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Atrovent 500 UDVs, 500 micrograms/ 2ml Nebuliser Solution

500 micrograms/2 ml microgram(s) Nebuliser solution

Boehringer Ingelheim International GmbHPA0775/012/003

Main Information

Trade NameAtrovent 500 UDVs, 500 micrograms/ 2ml Nebuliser Solution
Active SubstancesIpratropium bromide
Strength500 micrograms/2 ml microgram(s)
Dosage FormNebuliser solution
Licence HolderBoehringer Ingelheim International GmbH
Licence NumberPA0775/012/003

Group Information

ATC CodeR03BB Anticholinergics
R03BB01 ipratropium bromide


Licence Issued27/09/1985
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletNo document available
Public Assessment ReportNo document available
« Back